| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
34,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
18,050 |
Avg
Vol: |
18,000 |
| 52
Week Range: |
$238.6 - $238.6 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Quinn Anthony |
SVP, Chief Medical Officer |
• – – |
2012-07-19 |
4 |
AS |
$50.00 |
$95,000 |
D/D |
(1,900) |
20,035 |
|
- |
|
| Quinn Anthony |
SVP, Chief Medical Officer |
• – – |
2012-07-19 |
4 |
OE |
$0.95 |
$1,805 |
D/D |
1,900 |
21,935 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2012-07-18 |
4 |
AS |
$48.82 |
$323,091 |
D/D |
(6,618) |
0 |
|
- |
|
| Boess Carsten |
SVP, Chief Financial Officer |
• – – |
2012-07-18 |
4 |
OE |
$1.70 |
$11,251 |
D/D |
6,618 |
6,618 |
|
- |
|
| 667, L.p. |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,736,065 |
|
- |
|
| Fbb Associates |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
143,462 |
|
- |
|
| 14159, L.p. |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
135,739 |
|
- |
|
| Baker Bros. Investments Ii, L.p. |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
55,479 |
|
- |
|
| Baker Bros. Investments, L.p. |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
165,213 |
|
- |
|
| Baker/tisch Investments, Lp |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
206,800 |
|
- |
|
| Baker Biotech Fund Ii (a), L.p. |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,490 |
|
- |
|
| Baker Brothers Life Sciences Lp |
Director |
– • – |
2012-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,077,676 |
|
- |
|
| 14159, L.p. |
Director |
– • • |
2012-07-13 |
4 |
B |
$41.20 |
$36,503,200 |
I/I |
886,000 |
156,821 |
2.25 |
- |
|
| Baker Felix |
Director |
– • • |
2012-07-13 |
4 |
B |
$41.20 |
$36,503,200 |
I/I |
886,000 |
156,821 |
2.25 |
- |
|
| Tisch Thomas J |
Director |
– • – |
2012-07-12 |
4 |
B |
$41.20 |
$1,503,800 |
I/I |
36,500 |
352,521 |
2.1 |
- |
|
| Tisch Thomas J |
Director |
– • – |
2012-07-12 |
4 |
B |
$41.20 |
$1,503,800 |
D/D |
36,500 |
378,435 |
2.39 |
- |
|
| Tisch Daniel R |
10% Owner |
– – • |
2012-07-12 |
4 |
S |
$46.75 |
$1,365,100 |
D/D |
(29,200) |
186,357 |
|
- |
|
| Tisch Daniel R |
10% Owner |
– – • |
2012-07-11 |
4 |
S |
$45.73 |
$457,250 |
D/D |
(10,000) |
215,557 |
|
- |
|
| Tisch Daniel R |
10% Owner |
– – • |
2012-07-10 |
4 |
S |
$45.23 |
$452,250 |
D/D |
(10,000) |
225,557 |
|
- |
|
| Akkaraju Srinivas |
Former Director |
– – – |
2012-06-27 |
4 |
S |
$39.70 |
$12,444,005 |
I/I |
(313,451) |
1,026,832 |
|
- |
|
| Akkaraju Srinivas |
Former Director |
– – – |
2012-06-26 |
4 |
S |
$40.16 |
$1,157,661 |
I/I |
(28,827) |
1,340,283 |
|
- |
|
| Quinn Anthony |
SVP, Chief Medical Officer |
• – – |
2012-06-25 |
4 |
AS |
$40.65 |
$1,056,874 |
D/D |
(26,000) |
20,035 |
|
- |
|
| Tisch Daniel R |
10% Owner |
– – • |
2012-04-23 |
4 |
S |
$40.10 |
$120,300 |
I/I |
(3,000) |
44,750 |
|
- |
|
| Tisch Daniel R |
10% Owner |
– – • |
2012-04-20 |
4 |
S |
$39.66 |
$396,600 |
I/I |
(10,000) |
47,750 |
|
- |
|
| Patel Sanj K |
President & CEO |
• • – |
2012-03-23 |
4 |
AS |
$33.53 |
$1,676,410 |
D/D |
(50,000) |
1,031 |
|
- |
|
372 Records found
|
|
Page 9 of 15 |
|
|
